Objective-To determine the effect of adjuvant psychological therapy on the quality of life of patients with cancer.
Introduction
There is evidence that psychological ill health occurs in a substantial minority of cancer patients.' Consequently, increasing attention is being paid to the emotional and physical wellbeing (that is, the quality of life) of patients. Various psychotherapeutic procedures that aim to alleviate psychological morbidity have been tested in randomised controlled studies."9 Most of these clinical trials were limited to patients with breast cancer. Six of the studies reported significant improvement in psychiatric symptoms or social adjustment, or both, but two studies showed no improvement. Differences in stage of disease, type of psychological treatment, and outcome measures preclude any general conclusions.
In view of formidable methodological problems in this area, it is useful to outline major requirements that should be met in clinical trials of psychotherapy for patients with cancer. Firstly, ethical issues must be considered: in particular, whether a control group not given therapy is justified and, if so, what provisions can be made for patients in the control group who require psychiatric treatment because they are suicidal or suffer from major psychiatric illness. Secondly, since the terms counselling and psychotherapy are vague headings encompassing a wide variety of activities, it is important to describe as fully as possible the kind of therapy that is being evaluated. Thirdly, measures of outcome should be based on systematically developed questionnaires of known reliability and validity; moreover, such questionnaires should be standardised for cancer patients. Caution should be exercised in applying questionnaires developed for psychiatric patients to cancer patients. This caveat applies particularly to the measurement of depression. The use of scales that contain somatic items such as fatigue and weight loss may be misleading because these can be symptoms of cancer or its treatment as well as of depression. Fourthly, data about the type and stage of disease and about the treatment for cancer should be obtained. Lastly, patients should be randomly assigned to psychological treatment groups and no treatment control groups or to different treatment groups. We have adopted these criteria in the present study.
The aim of the present study is to determine the effect of adjuvant psychological therapy, a treatment programme we have developed, on the quality of life of patients with cancer.
Patients and methods
The study sample comprised a consecutive series of patients attending the Royal Marsden Hospital. The selection criteria were any form of cancer except cerebral tumours and non-melanoma skin cancers; a life expectancy (as judged by clinicians) of at least 12 months; age 
Results
The 12 month follow up is still in progress. In the present paper, we report results regarding the efficacy of therapy at eight weeks and four months offollow up. A total of 1260 patients were screened initially using the hospital anxiety and depression scale and mental adjustment to cancer scale. Of these patients 293 (23%) were found to be high scorers according to the criteria outlined above (including seven initially low scorers who became high scorers at the 12 month follow up) and were invited to take part in the study. A total of 96 patients (33%) refused, and 23 (8%) could not be randomised for other reasons (too ill, lost contact, etc). The remaining 174 patients were randomised. Eighteen of these patients (13 psychotherapy, five control) were lost to the study for the following reasons: three died before the eight week assessment, three had become too ill to be assessed, four refused; in one case follow up was omitted at the general practitioner's request; and seven patients had either moved away or could not be traced.
Comparison ofbaseline scores between these 18 patients and the 156 who were assessed at eight weeks or four months offollow up revealed no substantial differences ( The proportions ofboth therapy and control patients with clinical anxiety decreased sharply between screening and baseline assessments (78% and 77% at screening v 46% and 48% at baseline). This effect must be due in part to regression to the mean. A similar effect was not seen in depression or in fighting spirit and helplessness scores, which barely changed between screening and baseline assessments (table V) . In each case, however, regression to the mean was evident among patients who were above the selection criteria.
For example, of43 patients whose screening depression scores were 8 or higher, 33 reduced their scores and only 10 increased their scores from screening to baseline.
Clinicalanxiety-In the therapy group the proportion of severely anxious patients fell from 46% at baseline to 20% at eight weeks and 20% at four months; in the BMJ VOLUME 304 14 MARCH 1992 (18) 17 (22) Mkissing data 1 (1) 1 (1) I1 (1) 1 (1 (1) I1 (1) I1 (1) I1 (1) I1 (1) I1 (1) 2 (3) control group, there were only minor changes, from 48% at baseline t.o 41% at eight weeks and 43% at four months (table V) . Clinical depression -In the therapy group the proportion of depressed patients fell from 40% at baseline to 13% at eight weeks and 18% at four months; in the control group, there were only minor changes, from 30% at baseline to 29% at eight weeks and 23% at four months (table V) .
Poor psychological adjustment to cancer-In the therapy group the proportion of patients with low fighting spirit and high helplessness scores fell from 3.1% at baseline to 16% at eight weeks and 22% at four months; by contrast, in the control group there was little change, the proportions being 37% at baseline, 40% at eight weeks, and 35% at four months (table V) .
Included in the above figures are patients without clinical symptoms (low scorers) at baseline who developed such symptoms at eight weeks or four months of follow up; these comprised 25 patients (eight given therapy, 17 controls) scoring on anxiety, 22 (five given therapy, 17 controls) scoring on depression, and 28 (10 given therapy, 18 controls) scoring on fighting spirit or helplessness.
Discussion
Our aim was to conduct a rigorous, objective study.
We therefore carried out a randomised controlled trial in which randomisation was performed independently. Although the need for randomisation is widely accepted, there may be a loophole when patients are randomised by the clinician, who may be tempted to interfere with randomisation on clinical grounds.
POSSIBLE SOURCES OF BIAS
A possible source of bias in the present study -the loss of 18 patients after randomisation -was examined. Only four of these patients refused to enter the study; the rest were lost for reasons unconnected with their allocated treatment. Moreover, comparisons between the baseline scores of the lost patients and those who remained in the trial showed no substantial differences. 678~~~~~~~~~~~~~~B MJ VOLUME 304
Hence it seems unlikely that the loss of these patients contributed substantially to the observed responses to treatment.
Patients who refused to enter the study before randomisation could not have biased the observed effects of therapy, but the high proportion of refusers requires comment. It was disappointing to find that, despite our best efforts, a third of the patients with high scores who were invited to enter the trial declined to do so. Even so, this figure is lower than that reported in an uncontrolled study of outpatients with high anxiety and depression scores mainly suffering from advanced cancers attending a London hospital. Those We record our deep gratitude to the late, greatly missed, Professor T J McElwain who invited us to conduct this trial at Royal Marsden Hospital and who consistently encouraged and supported us. We thank the Cancer Research Campaign for their generous funding of our group and the COMPACT computer software which was used for data management. We also thank T Gladwell; our data manager; S Anderson, G Chesney, J Davidson, R Gardner, C Gorman, and H Saunders for their meticulous data collection and input; our consultant colleagues, who permitted access to their patients; and the patients, whose collaboration made this study possible and who taught us much.
Introduction
Health authorities need to take the views of A sample of 1500 residents was drawn systematically from the electoral registers of parishes within the health authority boundary. A single mailing was made in November 1990. Reply paid envelopes were provided.
No repeat mailing was done as we decided that allowing respondents complete anonymity was more important than any increase in response from a reminder mailing. Inducements, common in market research, 3 were not used as they may not increase response rates in health studies4 and could be contentious in the current political and social environment within the NHS. Data were analysed with the statistical package for the social sciences (SPSS-PC).5
Results
Seventy questionnaires were returned unopened, mainly because the addressee was no longer living at that residence. Of the remaining 1430 questionnaires, 704 (49 2%) were returned. The age and sex distribution of the respondents did not differ significantly from that of the district population as a whole.
People were asked how important they believed a selection of 10 services were. Table I shows these 
